Research and Markets (http://www.researchandmarkets.com/research/8gqmpf/2015_market) has announced the addition of the "2015 Market Segmentation Analysis of the German Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs and Physician Offices" report to their offering.
A new study of the major business opportunities emerging in the German cancer diagnostics market during the next five years.
The report examines trends in the German market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.
Rationale
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the German cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.
German Market Overview
Five-year test volume and sales projections.
Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
Estimated universe of laboratories performing cancer diagnostic testing.
Cancer statistics, etiology and recent developments in Germany.
Business Opportunities and Strategic Recommendations
Specific new product development opportunities with potentially significant market appeal during the next five years.
Design criteria for new products.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
Oncogenes
Biochemical Markers
Growth Factors
Colony Stimulating Factors
Hormones
Immunohistochemical Stains
Lymphokines
Supplier Shares, Sales and Volume Forecasts
Sales and market shares of major cancer diagnostic product suppliers by individual test.
Five-year test volume and sales forecasts for major tumor markers by market segment, including:
Hospitals
Commercial/Private Laboratories
Physician Offices
Instrumentation Review
Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.
Technology Assessment
Assessment of latest technologies and their potential applications for cancer diagnostic testing.
Review of competing/complementing technologies.
Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies
Strategic assessments of major suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.
Companies Mentioned
Abbott
AdnaGen
Arca Pharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Eiken Chemical
Elitech Group
Epigenomics
Enterix
Enzo Biochem
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
Quest Diagnostics
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zilla
For more information visit http://www.researchandmarkets.com/research/8gqmpf/2015_market
View source version on businesswire.com: http://www.businesswire.com/news/home/20150623005994/en/
Contacts:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: In Vitro Diagnostics
